E-LIB Suche - Ergebnisse für: Jarque, I.

1

ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE L..:

Poon, M. ; Walewski, J. ; Kim, T. M....
Hematological Oncology. 41 (2023) S2 - p. 141-142 , 2023

2

Lenalidomide in combination with R‐ESHAP in patients with r..:

Martín García‐Sancho, A. ; Baile, M. ; Rodríguez, G....
British Journal of Haematology. 203 (2023) 2 - p. 202-211 , 2023

Link: https://doi.org/10.1111/..

3

P1595: IFISTRATEGY: A SPANISH NATIONAL SURVEY ON STRATEGIES..:

Vallejo, C. ; Jarque, I. ; Fortún, J....
HemaSphere. 6 (2022) - p. 1476-1477 , 2022

Link: https://doi.org/10.1097/..

4

P1639: UTILITY OF NEXT GENERATION SEQUENCING TECHNIQUES TO ..:

Gonzalez-Lopez, T. J. ; Sanchez, R. ; Pastoriza, C....
HemaSphere. 6 (2022) - p. 1520-1521 , 2022

Link: https://doi.org/10.1097/..

5

PB2106: REDUCTION OF METHOTREXATE (MTX) LEVELS AFTER GLUCAR..:

De La Fuente, A. ; Peñalver, F. J. ; Herrera, P....
HemaSphere. 6 (2022) - p. 1977-1978 , 2022

Link: https://doi.org/10.1097/..

6

PMU80 DETERMINING THE EPIDEMIOLOGY, PATIENT FLOW, TREATMENT..:

Andrade, R. ; Bañares, R. ; Calleja, J.L....
Value in Health. 22 (2019) - p. S722 , 2019

Link: https://doi.org/10.1016/..

7

AUTOLOGOUS STEM CELL TRANSPLANTATION AS PART OF FIRST‐LINE ..:

Lopez‐Parra, M. ; Bellei, M. ; Rambaldi, A....
Hematological Oncology. 37 (2019) S2 - p. 98-99 , 2019

Link: https://doi.org/10.1002/..

8

PRO115 DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR E..:

Poveda, J.L. ; Badia, F.J. ; Chugani Mahtani, D....
Value in Health. 22 (2019) - p. S862 , 2019

Link: https://doi.org/10.1016/..

9

BENDAMUSTINE AS PART OF CONDITIONING REGIMEN FOR AUTOLOGOUS..:

Martín, A. ; Redondo, A.M. ; Valcárcel, D....
Hematological Oncology. 35 (2017) S2 - p. 192-193 , 2017

Link: https://doi.org/10.1002/..

10

Results of a prospective phase II trial with ofatumumab as ..:

Cabrero, M. ; Lopez‐Corral, L. ; de la Cruz, F....
Hematological Oncology. 35 (2017) S2 - p. 346-347 , 2017

Link: https://doi.org/10.1002/..

11

Lenalidomide in combination with R‐ESHAP in patients with r..:

Martín, A. ; Baile, M. ; Rodríguez, G....
Hematological Oncology. 35 (2017) S2 - p. 345-345 , 2017

Link: https://doi.org/10.1002/..

12

Cost-Utility of Idelalisib In Combination with Rituximab In..:

Casado, LF ; Hernandez, JA ; Jarque, I...
Value in Health. 20 (2017) 9 - p. A557 , 2017

Link: https://doi.org/10.1016/..

13

AUTOLOGOUS STEM CELL TRANSPLANTATION MAY POTENTIALLY ABROGA..:

Jiménez Ubieto, A. ; Grande, C. ; Caballero, D....
Hematological Oncology. 35 (2017) S2 - p. 221-222 , 2017

Link: https://doi.org/10.1002/..

14

PHASE 2 RANDOMIZED TRIAL COMPARING STANDARD RCHOP VERSUS BR..:

Gonzalez‐Barca, E. ; Carrillo, E. ; Grande, C....
Hematological Oncology. 35 (2017) S2 - p. 188-189 , 2017

Link: https://doi.org/10.1002/..

15

Pharmacoeconomic Analysis of The Use of Voriconazole, Posac..:

Grau, S ; Solano, C ; García-Vidal, C...
Value in Health. 18 (2015) 7 - p. A581 , 2015

Link: https://doi.org/10.1016/..